Former President Donald Trump's political allies are crafting a plan to increase his influence over the Federal Reserve, potentially even making him an "acting" member of the central bank’s board, according to The Wall Street Journal. Nick Timiraos, the Journal's Chief Economics Correspondent, discusses the implications if Trump wins in November. Former FDA Commissioner Dr. Scott Gottlieb weighs in on Moderna's partnership with OpenAI, the AI drug revolution, his own AI venture, and updates on the bird flu presence in America’s pasteurized milk. Plus, CNBC's Steve Kovach breaks down Alphabet and Microsoft earnings and explores the future of AI investment for the megacap tech companies. Nick Timiraos - 10:08Steve Kovach - 17:22Dr. Scott Gottlieb - 22:12.In this episode:Nick Timiraos, @NickTimiraosScott Gottlieb, @ScottGottliebMDJoe Kernen, @JoeSquawkBecky Quick, @BeckyQuickAndrew Ross Sorkin, @andrewrsorkinZach Vallese, @zachvallese Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related